
Cyclosporine Solution 0.09% Boosts Outcomes in Uncontrolled Dry Eye
A subgroup analysis of a Phase 4, open-label, single-arm, multicenter study demonstrated the benefit of cyclosporine (CsA) ophthalmic solution 0.09% (CEQUA) for patients with dry eye disease (DED) uncontrolled on CsA ophthalmic emulsion 0.05% (Restasis). …